ABSTRACT. The purpose of this study was to investigate the effect of breed on the pharmacokinetics and metabolism of caffeine (CF) and the hepatic metabolic capacity in sheep. CF was administered as a single intravenous dose of 5 mg/kg b.w. in Morkaraman (MK), Akkaraman (AK) and Anatolia Merino (AM) sheep breeds. The plasma levels of CF and its primary metabolites, theobromine (TB), paraxanthine (PX) and theophylline (TP), were measured using high-performance liquid chromatography. Pharmacokinetic parameters of CF and its metabolites were calculated. Plasma TB+PX+TP/CF metabolic ratio was determined as an alternative to CF clearance for the determination of hepatic metabolic capacity. In the three breeds, all kinetic parameters of CF differed significantly (P<0.05) except for volume of distribution. Elimination of CF was slow in the MK (Cl T ; 0.03 0.01 l hr/kg, t 1/2z ; 15.74 7.35 hr) and AM (Cl T ; 0.05 0.02 l hr/kg, t 1/2z ; 9.68 5.21 hr) breeds when compared with the AK breed (Cl T ; 0.08 0.01 l hr/kg, t 1/2z ; 6.84 0.79 hr). There was significant correlation (r 2 =0.904, P<0.01) between CF clearance and the plasma TB+PX+TP/CF ratio calculated at 7 hr after CF administration. The plasma TB+PX+TP/CF ratios were statistically different (P<0.05) among the breeds (MK, 0.155 0.062; AK, 0.468 0.107; AM, 0.254 0.099). These results suggest that the pattern of drug biotransformation should be consistently tested for all breeds within species. Further studies are needed to determine the biochemical and molecular events underlying such an effect. The activities of biotransformation enzymes affect either the pharmacological or toxicological impacts of drugs and xenobiotics. During the past decades, much of the detailed knowledge of enzymes responsible for biotransformation has been learned in laboratory animals and humans. In contrast, knowledge of biotransformation enzymes and various factors (breed, age) causing their variability in veterinary food-producing species is still incomplete [10,12,15,19,26,35].Genotyping and phenotyping are the 2 methods that are used today to assess the in vivo activity of biotransformation enzymes. However, the optimal method of describing actual enzyme activity is phenotyping because it is a reflection of the combined effects of genetic, environmental and endogenous factors on enzyme activity [25]. Phenotyping for drug metabolizing enzymes is defined as measuring its actual in vivo activity in an individual. This is performed by administrations of probe substrates for various isoforms of cytochrome P450 (CYP 450) and other enzymes and subsequent determination of appropriate pharmacokinetic parameters or is performed by using metabolism [12].Caffeine (CF) is now widely used to assess genetic, environmental and race/breed differences for some enzymes and the hepatic metabolic capacity (total activity of enzymes metabolizing CF) because of its pharmacokinetics and almost complete biotransformation by some CYP 450 enzymes in liver [17,23]. The primary metabolic pathway...